Simon Fredriksson

Dr. Simon Fredriksson is a Co-Founder and serves as Executive Vice President at Genagon Therapeutics. He previously served as Chief Executive Officer at Genagon Therapeutics. He served as Board Member at BioLamina. He is a Board Member of Olink Proteomics and CARTANA. He co-founded and served as Executive Vice President, Chief Scientific Officer, President and Chief Executive Officer at Olink Proteomics. He is an inventor of several patents and patent application on solution phase Proximity Ligation. He developed homogenous PLA during his graduate work and has further expanded the technology into a multiplexed protein detection tool for biomarker research. Previously he was a staff scientist at Stanford University working on protein based cancer biomarker detection technologies and high throughput genomics tools.